Experimental overexpression of miR-214 in HCC cells leads to suppression of E2F2, CDK3, and CDK6, cell-cycle arrest at the G1–S checkpoint, and disrupted proliferation of the cancer cells. Here, CDK6 is linked to hepatocellular carcinoma.